Penciclovir Recruiting Phase 1 Trials for Tumors / Triple Negative Breast Cancer (TNBC) / Head and Neck Carcinoma / Lung Cancer Non-Small Cell Cancer (NSCLC) / Colorectal Cancers / Melanoma / Other Solid Cancers / Bladder Cancers / Renal Cancers Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03289962A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors